NFKB1 and cancer: Since NF-κB expression is associated with inflammation-driven cancer (34), the decrease in NF-κB signal suggests a reduction in the inflammatory environment in the GI tract, potentially contributing to the suppression of tumor growth in the mid-segment of the small intestine.